Physician profile
Randall E Yee
NPI 1427049501
$6,197.60
in general payments reported to CMS, 2019-2025
34 companies · $453 in 2025
The $453 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,564 · 2020: $1,082 · 2021: $842 · 2022: $660 · 2023: $113 · 2024: $483 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $1,480.66 | 2019-2025 | |
| Forte Bio-Pharma LLC | $1,188.90 | 2019-2022 | |
| Smith+Nephew, INC. | $824.08 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Ultrabutton, Grafix Pl |
| Arthrex, INC. | $739.30 | 2019 | |
| Depuy Synthes Sales INC. | $420.38 | 2019-2025 | Monovisc, Orthovisc |
| Zyla Life Sciences, INC. | $181.88 | 2019 | |
| Dynasplint Systems INC. | $147.37 | 2019-2021 | |
| Abbott Laboratories | $130.01 | 2019-2023 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $112.09 | 2020-2021 | |
| Ethicon US, LLC | $92.90 | 2019-2025 | Ethicon |
| Linvatec Corporation | $92.46 | 2023-2025 | Allograft Tissue, Biobrace 23mm |
| Daiichi Sankyo INC. | $87.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $76.48 | 2019-2025 | Osseoti Reconstructive System, Persona |
| Nalu Medical, INC. | $72.78 | 2025 | Nalu Neurostimulation System |
| Aroa Biosurgery Incorporated | $69.20 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $61.51 | 2024-2025 | |
| Stryker Corporation | $49.17 | 2019 | |
| Baxter Healthcare | $44.68 | 2020 | |
| Biom'Up France Sas | $41.99 | 2020-2021 | |
| Redhill Biopharma INC. | $31.28 | 2020 | |
| Orthofix Medical, INC. | $30.58 | 2021-2022 | |
| Maxx Orthopedics, INC. | $28.70 | 2019-2024 | |
| Horizon Therapeutics Plc | $27.23 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.57 | 2019-2020 | |
| Bioventus LLC | $16.90 | 2020 | |
| Becton, Dickinson and Company | $16.85 | 2019 | |
| Anika Therapeutics, INC. | $16.25 | 2024 | Integrity |
| Vericel Corporation | $16.12 | 2020 | |
| Bard Access Systems, INC. | $16.06 | 2019 | |
| Kci USA, INC. | $13.86 | 2020 | |
| Medtronic USA, INC. | $13.37 | 2019 | |
| Organogenesis INC. | $12.70 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.09 | 2019 | |
| Kerecis Limited | $8.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.